1. Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. (2nd September 2022) Authors: Rodriguez, Cristina P; Kang, Hyunseok; Geiger, Jessica L; Burtness, Barbara; Chung, Christine H; Pickering, Curtis R; Fakhry, Carole; Le, Quynh Thu; Yom, Sue S; Galloway, Thomas J; Golemis, Erica; Li, Alice; Shoop, Jeffrey; Wong, Stuart; Mehra, Ranee; Skinner, Heath; Saba, Nabil F; Flores, Elsa R... Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 12(2022) Page Start: 1619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation. Issue 5 (22nd February 2021) Authors: Wu, H Helena; Wang, Benfan; Armstrong, Stephen R; Abuetabh, Yasser; Leng, Sarah; Roa, Wilson H Y; Atfi, Azeddine; Marchese, Adriano; Wilson, Beverly; Sergi, Consolato; Flores, Elsa R; Eisenstat, David D; Leng, Roger P Journal: Nucleic acids research Issue: Volume 49:Issue 5(2021) Page Start: 2740 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗